Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer
Authors
Kamposioras, K.Lim, K. H. J.
Williams, J.
Alani, M.
Barriuso, J.
Collins, J.
Marti, K.
Braun, M.
Mullamitha, S.
Hasan, J.
Alam, N.
Mahmood, S.
Finch, S.
Bayles, L.
King, J.
Saunders, M.
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2021
Metadata
Show full item recordAbstract
Background Since the beginning of the COVID-19 pandemic, multiple changes to the provision of cancer care has been introduced to maximize patient safety and protect staff. We aimed to identify factors influencing clinicians’ decision on treatment modification during the initial phase of the pandemic, and to assess its impact on outcomes in patients with colorectal cancer. Patients and Methods Electronic records of patients seen in a large United Kingdom tertiary cancer center was reviewed. The frequency and type of changes to systemic anticancer therapy , as well as the factors predicting clinicians’ decision were assessed. Results A total of 418 patients; mean age 63 ± 12 years and 57% male were included. More than half of the patients had modification to their treatment; with treatment delay (21%) or cancellation (10%), being the most common. Majority of patients on neoadjuvant treatment (97%) proceeded with treatment, with some form of treatment modification in 20%. Half of patients on adjuvant treatment had their treatment plan modified. Overall, a change in treatment was more likely in older patients (OR 1.028 [95% CI 1.010-1.047]; P = .002), and in patients who had already received higher number of cycles of systemic anticancer therapy (OR 1.040 [95% CI 1.016-1.065]; P = .001). A change in treatment was less likely further out of the first national lockdown (OR 0.837 [95% CI 0.758-0.925]; P < .001). Patients on third-line treatment were most likely to have alterations to their treatment plan (69%, n=33/48). Conclusion During the first wave of COVID-19 in the United Kingdom, clinicians adapted clinical practice in accordance to local and national guidance, especially amongst older patients and those on third-line treatment. Further real-world data are needed to document the important impact of changes to treatment on outcomes in patients with cancer.Citation
Kamposioras K, Lim KHJ, Williams J, Alani M, Barriuso J, Collins J, et al. Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer. Clin Colorectal Cancer. 2021.Journal
Clin Colorectal CancerDOI
10.1016/j.clcc.2021.11.010PubMed ID
34953674Additional Links
https://dx.doi.org/10.1016/j.clcc.2021.11.010Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clcc.2021.11.010
Scopus Count
Collections
Related articles
- How did we take care of our older cancer patients during the first COVID-19 wave? The French experience.
- Authors: Helissey C, Ghebriou D, Cessot A, Boudin L, Prieux C, Romeo E, Schernberg A, Grellier N, Joly C, Bauduceau O, Thibault C, Mamou E, Raynal G, Serey Eiffel S, Le Floch H, Ricard D, Brureau L
- Issue date: 2021 Jun
- The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis.
- Authors: Clark JJ, Dwyer D, Pinwill N, Clark P, Johnson P, Hackshaw A
- Issue date: 2021 Jan
- Trends in Treatment of Colorectal Cancer and Short-term Outcomes During the First Wave of the COVID-19 Pandemic in Sweden.
- Authors: Eklöv K, Nygren J, Bringman S, Löfgren J, Sjövall A, Nordenvall C, Everhov ÅH
- Issue date: 2022 May 2
- The "collateral damage" of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer.
- Authors: Goenka L, Anandaradje A, Nakka T, Kayal S, Dubashi B, Chaturvedula L, Veena P, Durairaj J, Penumadu P, Ganesan P
- Issue date: 2021 Sep 28
- Colorectal resections during the COVID-19 pandemic: a national survey of practice during first lockdown.
- Authors: Rajput K, Clifford RE, Barter R, Rajaganeshan R, Kalaiselvan R
- Issue date: 2022 Apr